¡¶°ÄÃÅÆ»¹ûÊÖ»ú±¨¼ÛÍø-¶ÄÇ®ÍøÕ¾Ñ§±¨¡·ÊÇÓÉÖØÇìÊнÌÓýίԱ»áÖ÷¹Ü¡¢°ÄÃÅÆ»¹ûÊÖ»ú±¨¼ÛÍø-¶ÄÇ®ÍøÕ¾Ö÷°ìµÄÁ¬ÐøÐÔÄÚ²¿×ÊÁÏ¡£Îª¸üºÃµØ·¢»ÓѧУҽѧ½ÌÓý½ÌѧµÄ¿ÆÑÐÕóµØºÍչʾ¿ÆÑгɹûµÄ´°¿Ú×÷Óã¬ÏÖÕ÷¸åÈçÏ£º
Ò»¡¢ÄÚÈÝ
»ù´¡Ñо¿¡¢ÁÙ´²Ò½Ñ§¡¢½ÌÓý½Ìѧ¡¢Ë¼¿¼Óë̽Ë÷¡¢µ÷²éÑо¿¡¢×ÛÊöµÈ·½Ãæ¸å¼þ¡£
¶þ¡¢ÂÛÎĸñʽ
1. ÂÛÎÄ»ù±¾×é³É²¿·Ö£º±êÌâ¡¢µ¥Î»¡¢ÐÕÃû¡¢ÕªÒª¡¢¹Ø¼ü´Ê¡¢ÕýÎÄ¡¢²Î¿¼ÎÄÏס¢»ù½ðÏîÄ¿¡£
2. ²Î¿¼ÎÄÏ׸ñʽ¾ÙÀý£º
£Û1£Ý ÇØXX£¬ÔÀXX£¬ÕÅXX£¬µÈ. ÌÇÄò²¡´óÊóÉöСÇòIL-18¡¢ICAM-1ºÍTNF-¦Á±í´ïµÄʵÑéÑо¿£ÛJ£Ý. ÖйúÌÇÄò²¡ÔÓÖ¾£¬2008£¨9£©£º541-543.
£Û2£Ý Tam FW£¬Riser BL£¬Meeran K£¬et al. Urinary monocyte chemoattractant protein-1 £¨MCP-1£© and connective tissue growth factor £¨CCN2£© as prognostic markers for
progression of diabetic nephropathy£ÛJ£Ý. Cytokine£¬ 2009£¬47£¨1£©£º37-42.
Èý¡¢Í¶¸åÓÊÏä
yy58556822@sina.com»òyy58556822@163.com¡£
ÁªÏµµç»°£º023-58556822
°ÄÃÅÆ»¹ûÊÖ»ú±¨¼ÛÍø-¶ÄÇ®ÍøÕ¾Ñ§±¨±à¼²¿
2020Äê6ÔÂ30ÈÕ